Eurofins Viracor Biopharma
You’re blazing a new path in the immuno-oncology drug development frontier. You need a partner who understands the complexity of biomarker research to develop and perform critical assays that help keep you moving toward market success. Eurofins Viracor Biopharma has over thirty-five years of experience supporting clinical research.
There are many complexities that make cell and gene therapy development challenging. It is crucial that the new gene reaches the correct cell without causing an unintended immune response.
Our new next-generation sequencing (NGS) assay that enables comprehensive genomic profiling of solid tumor samples...IS NOW VALIDATED FOR LIQUID(PLASMA) BIOPSIES, TOO!
Another powerful addition to the Eurofins Biopharma portfolio supporting Precision Oncology studies.